Skip to main content

Market Overview

BeneLein Technologies Joins Science Center


BeneLein Technologies, which develops novel bioprocesses that significantly lower the manufacturing cost of existing active pharmaceutical ingredients, has initiated R&D operations at the University City Science Center's Port business incubator in West Philadelphia. Through a contract relationship with a global, top 10 pharmaceutical company, BeneLein will test the commercial feasibility of its process for manufacturing a key antibiotic product. If successful, transforming other pharmaceutical manufacturing processes to greener, lower cost bioprocessing is likely to catch on quickly.

Through the conception and development of novel bioprocesses, BeneLein replaces costly chemical synthesis steps with more efficient biological processes. These processes also reduce environmental impact and increase the use of renewal feedstock. This means that these critical products can be produced in the US at a cost that can rival those of outsourced producers while being greener, ensuring security of product supply, and adhering to regulated quality standards.

“This was a perfect time for us to take control of our own destiny by initiating laboratory operations at the Science Center,” says Chief Executive Officer Doug Leinen. “It was critical for us to be located in a vibrant research and innovation community like University City, where an entrepreneurial infrastructure exists and where we can establish the networks we will need to grow our company.”

“BeneLein's technologies have the potential to bolster the pharmaceutical manufacturing sector both in the Greater Philadelphia region and beyond,” says Science Center President & CEO Stephen S. Tang, Ph.D. “Philadelphia has long been known as a center for pharmaceutical innovation, and we welcome BeneLein as the newest member of the Science Center's community of entrepreneurs.”

About The Science Center

The University City Science Center accelerates technology commercialization, regional economic development, and the market availability of life-enhancing scientific breakthroughs by bringing together innovations, scientists, entrepreneurs, funding, laboratory facilities, and business services. Established in 1963 and headquartered in Philadelphia, PA, the Science Center was the first, and remains the largest, urban research park in the United States. It provides services that range from incubator space with fully-equipped laboratories and “plug ‘n play” offices for entrepreneurs to path-breaking programs designed to demonstrate, nurture, and sustain new technology businesses and bring their benefits to the region and the world. For more information about the Science Center, go to

University City Science Center
Jeanne Mell, 215-966-6029
cell: 302-345-8130

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at